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Abstract:  Green  tea  has  been  receiving  considerable  attention  as  a  possible 
neuroprotective  agent  against  neurodegenerative  disease.  Epigallocatechin-3-gallate 
(EGCG) is the major compound of green tea. Calcium signaling has profound effects on 
almost all aspects of neuronal function. Using digital calcium imaging and patch-clamp 
technique, we determined the effects of EGCG on Ca
2+ signals in hippocampal neurons. 
The results indicated that EGCG caused a dose-dependent increase in intracellular Ca
2+ 
([Ca
2+]i). This [Ca
2+]i increase was blocked by depleting intracellular Ca
2+ stores with the 
endoplasmic  reticulum  Ca
2+  pump  inhibitor  thapsigargin  and  cyclopiazonic  acid. 
Furthermore, EGCG-stimulated increase in [Ca
2+]i was abolished following treatment with 
a PLC inhibitor. However, EGCG inhibited high-voltage activated Ca
2+ currents (IHVA) and 
NMDA-induced inward currents (INMDA). These data suggest that EGCG triggers a cascade 
of events: it activates phospholipase C (PLC), mobilizes intracellular Ca
2+ stores, raises the 
cytosolic Ca
2+ levels, and inhibits the VGCC and NMDA receptors-mediated Ca
2+ influx 
through a process that remains to be determined. 
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1. Introduction 
Green tea polyphenols are natural plant flavonoids and comprise many types of catechin. Among 
them,  (−)-epigallocatechin  gallate  (EGCG)  is  the  major  polyphenol  component  and  primarily 
responsible for the green tea effect. Previous studies on the biological activities of EGCG were mostly 
focused  on  its  beneficial  effects,  including  antioxidant  [1,2],  anticarcinogenic  [3–5],  and 
anti-inflammatory properties  [6]. Also,  EGCG can penetrate the brain’s  blood  barrier  [7]  and  has 
neuroprotective effects. 
Calcium (Ca
2+) is a ubiquitous intracellular signal responsible for controlling numerous cellular 
processes, such as fertilization, proliferation, development, learning and memory [8]. Maintenance of 
intracellular Ca
2+ homeostasis is crucial for cell survival. The site, magnitude, and kinetics of Ca
2+ 
changes determine the biological consequences of Ca
2+ signaling in the neurons [9–11]. One biological 
action attributed to EGCG is the ability to influence intracellular Ca
2+([Ca
2+]i) in both non-excitable 
and excitable cells. EGCG reportedly attenuates the a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid  (AMPA)-induced  increase  in  [Ca
2+]I  in  hippocampal  neurons  [12].  In  addition,  EGCG  also 
reduced  both  N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (NMDA)  and  kainate-induced  [Ca
2+]i 
increase by attenuating both ionotropic Ca
2+ influx and Ca
2+-induced Ca
2+ release (CICR) in PC12 
cells,  but  it  did  not  affect  matabotropic  receptor-mediated  Ca
2+  release  [13].  These  studies  have 
focused to elucidate the protective effects of EGCG after the treatment of cells with cytotoxic agents. 
Recently,  it  has  been  demonstrated  that  EGCG  mediated  stimulation  of  [Ca
2+]i  in  cultures  of  rat 
hippocampal  neurons  is  partially  responsible  for  the  death  of  hippocampal  neurons  induced  by 
EGCG [14]. Excessive elevation of [Ca
2+]i produces deleterious effects and results in cell death. Thus, 
it  is  essential  for  cells  to  carefully  buffer  intracellular  calcium  and  to  precisely  regulate  calcium 
entry [15].  We  hypothesized  that  EGCG  at  low  concentrations  could  result  in  a  relatively  small 
increase in [Ca
2+]i, which would be compensated for by the calcium-buffering mechanisms of cells. 
However,  high-concentration  EGCG  produced  excessive  elevation  of  [Ca
2+]i  which  was  possible 
beyond the buffering capacity of neurons and led to a cascade of cellular pathological events [14]. 
Currently, the detailed mechanisms by which EGCG regulated [Ca
2+]i in neurons remain unclear. 
The present study characterized EGCG-regulated Ca
2+ signaling by employing calcium imaging and 
whole cell patch-clamp techniques. The results indicated that EGCG increased [Ca
2+]i in hippocampal 
neurons  in  a  dose-dependent  manner.  The  regulation,  which  was  mediated  by  intracellular  stores 
mobilization via activation of a PLC-IP3 pathway, led to suppression of high-voltage activated Ca
2+ 
currents  (IHVA)  and  NMDA-induced  inward  currents  (INMDA).  These  data  shed  new  light  on  the 
understanding of pharmacological action of EGCG in hippocampal neurons.   Int. J. Mol. Sci. 2011, 12                         
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2. Results and Discussion 
2.1. EGCG Elevates [Ca
2+]i in Rat Hippocampal Neurons in a Dose-Dependent Manner 
In the first set of experiments, we employed the [Ca
2+]i imaging technique to study the dynamic 
alteration of intracellular calcium mediated by EGCG in primary culture of rat hippocampal neurons. 
From the results, the effect of EGCG was significant at 10 µM (P < 0.05, n = 29), and reached a 
maximal  level  at  a  concentration  of  100  µM  (Figure  1B).  The  EC50  for  potentiation  effect 
was 11.6 ±  1.6 µM (fitted with Sigmaplot version 9.0 to the Hill equation). Calcium mobilization was 
initially detected 100 s following the application of 30 µM EGCG and rapidly reached a plateau in 
236 ±  48 s. Repeated 30 µM EGCG stimulation produced equal response and this response was fully 
reversed after washout with ACSF. The response were detected in  59% (34 of 58 cells tested) of 
neurons, resulting in a 70.8 ±  11.0% increase over basal levels. 
Figure 1. EGCG induced increase of intracellular calcium levels in hippocampal neurons. 
(A) Summary data of increases in [Ca
2+]i for each dose of EGCG from three independent 
experiments. [Ca
2+]i increase was recorded as described in the Experimental section and 
expressed  as  [(F340/F380)S-F340/F380)B]/(F340/F380)B.  *  P < 0.05  vs.  corresponding 
value in control cultures; (B) Hippocampal neurons were treated with 30 µM EGCG for the 
designated time. The arrows indicate the time of EGCG application or washout. 
 
2.2. EGCG-Evoked Enhancement of [Ca
2+]i Depends on the Release from Intracellular Calcium Store 
and Ca
2+ Influx 
To explore the respective contribution of Ca
2+ influx from the extracellular compartment or the 
release from intracellular Ca
2+ stores on EGCG-induced [Ca
2+]i elevation in hippocampal neurons, the 
standard extracellular solution was replaced by Ca
2+-free solution. In the absence of extracellular Ca
2+, 
30 µM EGCG was able to induce a significant increase of basal [Ca
2+]i (54 ±  8.1% over unstimulated 
level, n = 28 ), although the magnitude of elevation (Figure 2A) was less than that in the presence of 
extracellular Ca
2+ (Figure 2B). This suggests that calcium release from intracellular stores was partly 
responsible for the induced Ca
2+ elevation. As shown in Figure 2B, EGCG induced Ca
2+ increase was 
blunt  while  Ca
2+-free  medium  was  applied,  but  recovered  again  after  reperfusion  with 
Ca
2+-containing medium. Int. J. Mol. Sci. 2011, 12                         
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The importance of Ca
2+ release from intracellular stores in triggering the elevation of [Ca
2+]i was 
further investigated. After pre-incubation with 1 µM thapsigargin to deplete the intracellular calcium 
store in neurons bathed in Ca
2+-containing medium, EGCG failed to evoke a significant increase in 
[Ca
2+]i (n = 31, Figure 2C). Similar results were obtained when cyclopiazonic acid (CPA), an inhibitor 
of  sarcoplasmic/endoplasmic  reticulum  Ca
2+-ATPase,  was  applied  (n =  27,  Figure  2D).  These 
experiments  indicated  that  Ca
2+  release  from  intracellular  stores  was  necessary  and  sufficient  for 
EGCG-induced [Ca
2+]i rise.   
Figure 2. EGCG-mediated increase in [Ca
2+]i depends on release of Ca
2+ from intracellular 
calcium stores and Ca
2+ influx. (A) Superfusion of cultured neurons was switched to a 
Ca
2+-free solution when 30 M EGCG was added; (B) [Ca
2+]i increase was halted while 
Ca
2+-free  solution  was  applied  and  restored  after  switching  back  to  Ca
2+-containing 
solution during EGCG-induced increase in [Ca
2+]i. +Ca
2+, Ca
2+-containing ACSF applied. 
−Ca,  Ca
2+-free  ACSF  applied;  (C)  Application  of  1  M  thapsigargin  to  delete  the 
intracellular  calcium  store  completely  blocked  EGCG-induced  [Ca
2+]i  increase  in 
hippocampal neurons; (D) Application of 10 M CPA to deplete the intracellular calcium 
store,  EGCG  failed  to  evoke  a  significant  increase  in  [Ca
2+]i.  The  experiments  were 
repeated at least three times and representative data are shown for each treatment.   
 
 
2.3. Activation of Phospholipase C (PLC) Signaling Pathways is Essential for EGCG-Stimulated 
[Ca
2+]i Elevation   
To ascertain which intracellular signaling pathway is activated in EGCG-induced Ca
2+ release from 
intracellular calcium stores, cells were treated with 10 M U73122, a PLC inhibitor. Notably, the Int. J. Mol. Sci. 2011, 12                         
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increase in intracellular calcium levels by EGCG was prevented by pre-treatment with U73122 (n = 20, 
Figure 3A), whereas U73343, an inactive analog of U73122 (without inhibitory activity), did not alter 
EGCG-stimulated [Ca
2+]i elevation (n = 21, P > 0.05).   
Activation  of  PLC  is  known  to  stimulated  PI  hydrolysis,  IP3  and  1,2-diacylglycerol  (DAG) 
production. Subsequently, IP3 stimulates the Ca
2+ release from endoplasmic reticulum (ER) stores; 
DAG  leads  to  activation  of  protein  kinase  C  (PKC).  To  test  which  pathway  was  involved  in 
EGCG-mediated  elevation  of  [Ca
2+]i,  primary  cultured  hippocampal  neurons  were  pretreated  with 
heparin (20 mg/mL, a competitive antagonist of IP3), EGCG-evoked responses were attenuated to 
39.6 ±  4.1% over basal levels (n = 12, P < 0.05 vs. EGCG alone). When cells were treated with PKC 
inhibitor GF109203X (2 M), the stimulation effects of EGCG were not noticeably altered. The results 
suggested that the potentiation effect of EGCG was partially dependent on the activation of IP3. To 
determine whether coupling to the AC signaling pathway was affected by EGCG, cells treated with 
pCPT-cAMP, a membrane permeable cAMP analog,  was  examined.  In contrast,  pretreatment  with 
200 M pCPT-cAMP for 3 min had no effect on the increase in EGCG-mediated intracellular calcium 
levels (n = 19, P > 0.05). Meanwhile, H-89, a permeable PKA inhibitor, did not alter EGCG-stimulated 
elevation (n = 23, P > 0.05). These data suggested that EGCG mediated calcium signaling was not 
dependent on PKA pathway, but a PLC dependent pathway. 
Figure  3.  Activation  of  phospholipase  C  (PLC)  signaling  pathways  mediates 
EGCG-induced  [Ca
2+]i  elevation.  (A)  Pretreatment  with  10  M  U73122  blocked 
EGCG-induced  [Ca
2+]i  increase  in  hippocampal  neurons  (n  =  20).  Experiments  were 
repeated at least 3 times; (B) Summary data of the results with U73122, U73343 (10 M), 
heparin (20 mg/mL), GF109203X (2 M), p-CPT-cAMP (200 M) and H-89 (30 M) 
preincubation on EGCG-mediated elevation in hippocampal neurons. * P < 0.05 compared 
with EGCG alone.   
 
2.4. Voltage-Gated Calcium Channel and Receptor-Operated Calcium Channel Contribute to the 
Increase of [Ca
2+]i 
Although we demonstrated that Ca
2+ influx from the extracellular compartment contributed to the 
EGCG induced [Ca
2+]i elevation, the exact pathway involved in this regulation is unclear. To address 
this issue, we first employed verapamil to block voltage-gated calcium channels (VGCC). As shown in 
Figure  4A,  10  µM  verapamil  prevented  the  potentiating  effect  of  30  µM  EGCG  on  intracellular Int. J. Mol. Sci. 2011, 12                         
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calcium levels from 70.8 ±  11.0% to 56.3 ±  7.5% (n = 21, P < 0.05).   
Next,  the role of receptor-operated calcium  channels  (ROCC) in  this  process  was  checked.  As 
depicted  in  Figure  4B,  50  µM  DL-2-amino-5  phonovaleric  acid  (D-AP5)  attenuated  the 
EGCG-induced  elevation  of  [Ca
2+]i.  The  maximal  increases  in  [Ca
2+]i  over  basal  levels  were 
51.7 ±  7.2% (n = 19, P < 0.05). However, 10 µM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), a 
selective AMPA/kainite receptor competitive antagonist, did not produce any inhibition on EGCG 
induced elevation of free calcium in the neurons (Figure 4C). This result indicated that activation of 
the NMDA receptor contributed to the calcium influx stimulated by EGCG in hippocampal neurons.   
Figure  4.  Voltage-gated  calcium  channels  and  receptor-operated  calcium  channels 
contribute to EGCG-induced Ca
2+ influx. (A) Application of 10 µM verapamil for 3 min 
prior  to  the  addition  of  30  µM  EGCG  reduced  the  drug-stimulated  [Ca
2+]i  elevation 
(n = 21); (B) Pretreatment with 50 µM D-AP5 for 3 min before the addition of 30 µ M 
EGCG reduced the drug-stimulated [Ca
2+]i elevation (n = 19); (C). 30 µM CNQX failed to 
have an effect on EGCG-stimulated [Ca
2+]i elevation (n = 23); (D) Summary data of the 
results with verapamil, D-AP5 and CNQX preincubation on EGCG-mediated elevation in 
hippocampal neurons. *P < 0.05 compared with EGCG alone.   
 
2.5. EGCG Suppresses IHVA and INMDA via Elevating Intracellular Ca
2+ Concentration 
To  further  determine  the  roles  of  VGCC  and  NMDA  receptor  in  the  EGCG  induced  [Ca
2+]i 
elevation,  the  whole  cell  patch-clamp  technique  was  employed  to  study  the  effects  of  EGCG  on 
high-voltage-activated calcium currents (IHVA) and NMDA-induced inward currents (INMDA). IHVA were Int. J. Mol. Sci. 2011, 12                         
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elicited by a depolarization from holding potential of −80 mV to +10 mV. EGCG 30 µM caused a 
reduction in IHVA from 63.2 ±  5.9 pA.pF
−1 to 46.7 ±  5.3 pA.pF
−1(n = 21, P < 0.05). IHVA decreased by 
EGCG was irreversible after EGCG was washed out (Figure 5A). The cells were further dialyzed with 
high concentration of fast Ca
2+ chelator BAPTA (15 mM), which is sufficient to maintain [Ca
2+]i at a 
nanomolar level. As shown in Figure 5B, BAPTA almost abolished EGCG-induced inhibitory effect 
completely (n = 8, P < 0.05 vs. EGCG alone). These results revealed that the inhibition induced by 
EGCG was Ca
2+-dependent.   
NMDA (100 µM), an agonist of NMDA receptors, generated inward whole-cell membrane currents 
(INMDA) at a holding potential of −50 mV in cultured hippocampal neurons. The currents were blocked 
by the NMDA antagonist D-AP5, but not by the non-NMDA glutamate receptor antagonist CNQX 
(data not  shown).  As depicted in  Figure  5C,  with  treatment  with  EGCG (30  µM) for 3 min, the 
amplitude of INMDA was decreased by 62.9 ±  6.1% (n = 10, P < 0.05), whereas the inhibitory effects of 
EGCG on INMDA were blocked by addition of BAPTA (n = 9, Figure 5D). 
Figure 5. The EGCG-induced inhibitory effect on IHVA and  INMDA are Ca
2+-dependent. 
(A) 30  µM  EGCG  reversibly  decreased  high-voltage-activated  (HVA)  Ca
2+  currents  in 
primary cultured hippocampal neurons. Voltage protocol is shown on the top; (B) Representative 
trace showing dialysis with 15 mM bis-(o-aminophenoxy)-N,N,N’,N’-tetraacetic acid (BAPTA) 
significantly  reduced  the  inhibitory  modulation  of  EGCG  on  IHVA;  (C)  30  µM  EGCG 
reversibly decreased NMDA activated currents in primary cultured hippocampal neurons; 
(D) Representative traces showing dialysis with 15 mM BAPTA significantly attenuated 
the inhibitory effects of EGCG.   
 Int. J. Mol. Sci. 2011, 12                         
 
749 
2.6. Discussion 
In the present study, we found that EGCG elevated [Ca
2+]i in a dose-dependent manner in cultured 
hippocampal neurons, which was initially driven by Ca
2+ release from intracellular stores. Our data 
further demonstrated that EGCG induced inhibition of IHVA and INMDA was mediated by elevation of 
intracellular calcium through activation of a PLC-IP3 pathway. This biochemical cascade induced by 
EGCG is thought to be causative for the neuroprotective/neurotoxic effects of EGCG exposure.   
EGCG, as the main catechin polyphenols of tea, has been investigated experimentally. Attention has 
already been paid to the effects of EGCG on the nervous system in previous investigations. It has been 
reported that EGCG exerts neuroprotective effects in various models of toxicity induced by ischemia, 
glutamate, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP), oxidative stress and A   
peptides  [13,16–18].  In  contrast  to  the  neuroprotective  effects  of  the  EGCG,  increasing  evidence 
indicates that there is a concentration-dependent window of pharmacological action, in which, at high 
concentrations, EGCG has pro-oxidant/pro-apoptotic activity [19,20]. EGCG showed some maternal 
toxicity and reduced the growth rate of offspring in company with a slight increase in pup loss at high 
dose in genotoxity and teratogenicity studies [21,22]. And EGCG increased DNA strand breakage in 
purified blood lymphocytes at high doses [23]. More similarly, EGCG was reported to decrease the 
neuronal activity of medial vestibular nuclear neurons by playing a role in decreasing the neuronal 
activity  of  contralateral  vestibular  nuclei  [24].  More  recently,  EGCG  was  found  to  block  the 
voltage-gated sodium channel currents (INa) at the concentration of 400 µM and higher in hippocampal 
neurons [25].   
[Ca
2+]i. is central to multiple signal transduction pathways to accomplish a variety of biological 
functions. Our result is in agreement with a previous report that EGCG could cause a [Ca
2+]i elevation 
in a dose-dependent way [14]. Two major intracellular sources contribute to [Ca
2+]i mobilization: an 
intracellular  release  through  plasma  membrane  channels  and  a  internal  reservoir  in  the  ER  and 
mitochondria [26]. Our data showed that EGCG could still induce an increase in [Ca
2+]i in the absence 
of extracellular Ca
2+ and was abolished in cells that were depleted of intracellular calcium stores by 
thapsigargin and CPA, which suggested that the mobilization of Ca
2+ in the ER was necessary and 
sufficient  for  this  process.  However,  inhibition  of  EGCG-induced  [Ca
2+]i  increase  by  removal  of 
extracellular  Ca
2+  recovered  again  after  reperfusion  with  Ca
2+-containing  medium.  These  results 
suggest that Ca
2+ influx is partly involved in the EGCG induced calcium elevation. In our present 
study, a large proportion of EGCG-induced elevation of [Ca
2+]i was still apparent in the presence of 
VGCC and ROCC blockers, which suggested that these entry pathways did not represent the principal 
mode of elevation of [Ca
2+]i. Verapamil and D-AP5 slightly reduced EGCG-induced increase in [Ca
2+]i 
in  hippocampal  neurons.  However,  EGCG  inhibited  IHVA  and  INMDA,  suggesting  that  the 
EGCG-induced Ca
2+ influx occurred mainly though other pathways. Capacitative calcium entry (CCE) 
via store-operated calcium channel is considered to be the major mechanism for influx of Ca
2+ in a 
nonexcitable  cell  system.  It  is  generally  believed  that  CCE  operation  is  nonexistent  in  neurons, 
although there were some disagreements [27]. Although our data did not find the occurrence of CCE in 
cultured hippocampal neurons, this pathway could not be excluded to be involved in EGCG-induced 
Ca
2+ influx. 
 Int. J. Mol. Sci. 2011, 12                         
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Excessive  elevation  of  [Ca
2+]i  would  result  in  intracellular  calcium  overload,  which  triggers  a 
cascade of events leading to cell death. Calcium-buffering mechanism is essential for cells to reduce 
[Ca
2+]i. One target of intracellular calcium is voltage-dependent and ligand-gated ion channels [28]. 
Intracellular  calcium  can  inactivate  these  channels  by  binding  directly  to  ion  channels  or  via 
Ca
2+-dependent  enzymes,  such as calmodulin and calcineurin  [29].  Ca
2+-dependent inactivation  of 
HVA  Ca
2+  currents  restricts  the  entry  of  Ca
2+  into  the  cytoplasm,  which  is  a  negative  feedback 
mechanism between Ca
2+ entry and the intracellular Ca
2+ concentration [30]. This mechanism was 
reported to be involved in nicotine-induced neuroprotection [31]. The present study demonstrated that 
EGCG reversibly inhibited IHVA and INMDA in primary cultured hippocampal neurons. Chelation of 
intraculluar Ca
2+ with BAPTA reduced the effects of EGCG, which suggested that EGCG induced 
inhibition of IHVA and INMDA was dependent on Ca
2+ release from the intracellular stores. We argue that 
this type of coordinated modulation in signaling processes might protect neurons from Ca
2+ overload. 
EGCG is known to bind to several proteins and affects the activity of enzymes and receptors. It has 
been reported to act through phosphoinositide 3-kinase (PI 3-kinase), Akt/protein kinase B (Akt/PKB), 
tyrosine kinases, protein kinase C (PKC), and mitogen activated protein kinase (MAP kinase) signaling 
cascades  [32].  Inhibitory  or  stimulatory  actions  at  these  pathways  are  likely  to  influence  cellular 
function  profoundly.  However,  in  our  experiments,  the  limb  of  these  signaling  cascades  did  not 
participate in the EGCG-induced elevation of [Ca
2+]i. A clear understanding of the signal transduction 
mechanisms  is  a  key  to  the  evaluation  of  action  of  EGCG,  either  as  a  neuroprotective  agent  or 
neurotoxic agent [33]. In our study, inhibitors of PKA and PKC did not alter the effects of EGCG. In 
contrast,  blockade  of  IP3  receptors  with  heparin  or  depletion  of  intracellular  calcium  store  with 
thapsigargin  and  CPA  disrupted  the  EGCG-induced  increase  in  [Ca
2+]i.  These  data  indicated  that 
EGCG stimulated [Ca
2+]i via PLC-IP3 pathway in hippocampal neurons. 
3. Experimental Section   
3.1. Materials 
EGCG,  U-73122,U-73343,  p-CPT-cAMP,  CPA,  cyclopiazonic  acid,  NMDA,  H-89, 
DL-2-amino-5-phos-phonovaleric  acid  (AP-5),  6-cyano-7-nitroquinoxaline-2,3-dione  (CNQX), 
heparin, GF109203X, verapamil, and thapsigargin were purchased from Sigma (St. Louis, MO, USA). 
Fura-2/AM was obtained from Biotium (Hayward, CA, USA). DMEM/F12 and B27 supplement were 
obtained  from  Gibco  Invitrogen  Corporation  (Carlsbad,  CA,  USA).  Other  general  agents  were 
available  commercially.  Other  agents  were  purchased  from  commercial  suppliers.  Agents  were 
prepared as stock solutions with sterile water except difedipine, U-73122, U-73343 and Fura-2/AM, 
which were dissolved in dimethylsulfoxide (DMSO) and stored at −20 °C . They were diluted to the 
final concentrations before application. The final concentration of DMSO was <0.05%. No detectable 
effect of the vehicles was found in our experiments. 
3.2. Cell Culture 
Neonatal SD (Sprague-Dawley) rats (day 0–3) of both sexes were obtained from the Center for 
Disease Control of Hubei Province, China. All experiments were conducted in accordance with the Int. J. Mol. Sci. 2011, 12                         
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National Institutes of Health Guide for the Care and Use of Laboratory Animals. All experiments 
conformed to named local guidelines on the ethical use of animals and all efforts were exerted to 
minimize  the  number  of  animals  used  and  their  suffering.  Neurons  were  isolated  as  previously 
described with some modification [25]. Briefly, hippocampi of newborn rats were dissected and rinsed 
in ice cold dissection buffer. Blood vessels and white matter were removed and tissues were incubated 
in 0.125% trypsin for 25 min at 37 °C . Neurons were collected by centrifugation and resuspended in 
Dulbecco’s  modified  Eagle’s  medium  (DMEM)  and  F-12  supplement  (1:1)  (Gibco  Invitrogen 
corporation) with 10% fetal bovine serum (heat-inactivated, Hyclone), 2 mM L-glutamine (Sigma), and 
Penicillin (100 U/mL)-streptomycin (100 U/mL). Cells were plated at a density of 10
4–10
5 per 35 mm
2 
on coverslides precoated with poly-L-lysine and kept at a 37 ° C in a 5% CO2 incubator. After 24 h, the 
culture  medium  was  changed  to  DMEM  medium  containing  2%  B27  and  2 mmol/L  glutamine. 
Astrocytes were minimized by treating the culture with cytarabine (10 μM) on day 3. The medium was 
replaced with fresh medium every 3 days. Experiments were performed on day 5–7.   
3.3. Calcium Imaging Experiment 
Digital calcium imaging was performed as described by Ming et al. [34]. Hippocampal neurons 
were washed three times with 1 μmol/L Fura-2/AM in artificial cerebrospinal fluid (ACSF, containing 
140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM glucose and 10 mM HEPES, pH 7.3) 
then incubated in the same solution for 30 min at 37 ° C. In calcium-free experiments, EGTA (100 μM) 
was  substituted  for  CaCl2.  Before  each  experiment,  the  coverslides  were  mounted  on  a  chamber 
positioned on the movable stage of an inverted Olympus Ⅸ-70 microscope equipped with a calcium 
imaging system (TILL Photonics GmbH, Grä felfing, Germany), and superfused by ACSF for 10 min. 
Fura-2/AM loaded cells were illuminated at 340 nm for 150 ms and 380 nm for 50 ms at 1-s intervals 
using a TILL Polychrome monochromator. Fura-2 fluorescence emission was imaged at 510 nm by an 
intensified cooled charge coupled device (TILL Photonic GmbH) through an X-70 fluor oil immersion 
lens (Olympus) and a 460 nm long-pass barrier filter. F340/F380 fluorescence ratios were generated by 
TILLvision 4.0 software. Paired F340/F380 fluorescence ratio images were acquired every second for 
[Ca
2+]i. The intracellular free calcium concentration is presented as the ratio of the fluorescence signals 
obtained (340/380 nm). All experiments were repeated at least three times using different batches of cells. 
3.4. Whole Cell Patch Clamp Recording 
The procedure for whole cell patch-clamp recording was described in our previous study [35]. 
Currents were recorded with whole-cell patch-clamp technique, using an EPC-10 amplifier (HEKA, 
Lambrecht, Germany) controlled by the Pulse/PulseFit software (HEKA, Southboro, Germany). Data 
were acquired at a sampling rate of 10 kHz and filtered at 3 kHz. The pipette tips were heat-polished 
and have resistances of 2–4 MΩ when filled with intracellular buffer. The pipette solution used to 
record calcium currents consisted of (in mM) CsCl 100, MgCl2 2.0, Na2ATP 5.0, egtazic acid 11, 
HEPES 10, TEA-Cl  20, creatine phosphate 20, and the  pH  was  adjusted to  7.2 with  CsOH. The 
extracellular solution composed of (in mM) NaCl 110, KCl 5.0, CaCl2 5.0, MgCl2 1.0, HEPES 10, 
Glucose 11, 4-AP 5.0, TEA-Cl 25, TTX 0.5 ×  10
−3 and the pH was adjusted to 7.4 with NaOH. NMDA 
currents  were  recorded  using  electrodes  filled  with  (concentration  in  mM)  cesium  gluconate  135, Int. J. Mol. Sci. 2011, 12                         
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CsCl5, CaCl2 5.0, MgCl2 1.0, HEPES 10, Glucose 11, pH 7.2, with Tris base, and the bath solution 
contained (in mM) NaCl 140, KCl 5, CaCl2 2.5, HEPES 10, Glucose 10, TTX 0.5 ×  10
−3, pH 7.4 with 
Tris base. 100 µM NMDA was applied to cells for 15 s using a modified Y-tube. Drug actions were 
measured only after steady-state conditions reached, which were judged by the amplitudes and time 
courses of currents remaining constant.   
3.5. Statistical Analysis 
The  amplitudes  of  [Ca
2+]i  elevation  over  the  basal  were  represented  as  the  difference  between 
baseline  level  [(F340/F380)B]  and  the  peak  amplitude  [(F340/F380)S]  response  to  the  stimulation, 
which was shown as [(F340/F380)S-F340/F380)B]/(F340/F380)B. Data are presented as mean ±  SEM. 
Data were analyzed using SPSS 10.0 software. Student’s t-test or one-way ANOVA was used to test for 
significance. Differences were considered significant at P < 0.05.   
4. Conclusions 
Results  presented  here  suggested  that  EGCG  triggered  a  cascade  of  events:  it  activated 
phospholipase C, mobilized intracellular calcium stores, raised the cytosolic Ca
2+ levels, and inhibited 
the VGCC and NMDA receptor-mediated Ca
2+ influxes. Although the mechanisms by which EGCG 
raised  [Ca
2+]i  and  inhibited  IHVA  and  INMDA  in  cultured  hippocampal  neurons  remain  a  matter  of 
conjecture, our results may help to understand the neurotoxicity and officinal value of EGCG. 
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